probenecid has been researched along with Facial Pain in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
Excerpt | Relevance | Reference |
---|---|---|
"Probenecid has been widely used in the treatment of gout, but evidence suggests that it may also have antinociceptive effects in different inflammatory and pain conditions." | 1.42 | Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat. ( Bohár, Z; Fejes-Szabó, A; Nagy-Grócz, G; Párdutz, Á; Pődör, B; Tajti, J; Tar, L; Toldi, J; Vámos, E; Vécsei, L, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fejes-Szabó, A | 1 |
Bohár, Z | 1 |
Nagy-Grócz, G | 1 |
Vámos, E | 1 |
Tar, L | 1 |
Pődör, B | 1 |
Tajti, J | 1 |
Toldi, J | 1 |
Vécsei, L | 1 |
Párdutz, Á | 1 |
1 other study available for probenecid and Facial Pain
Article | Year |
---|---|
Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat.
Topics: Analgesics; Animals; Disease Models, Animal; Facial Pain; Formaldehyde; Injections, Intraperitoneal; | 2015 |